CombinatoRx, Inc. was a Cambridge/Boston, Massachusetts biopharmaceutical company (SEC CIK 0001135906, SIC 2834 Pharmaceutical Preparations, incorporated in Delaware) that pursued combination drug discovery — screening pairs of approved drugs for synergistic therapeutic effects. - View it on GitHub